In recent trading session, T2 Biosystems Inc (NASDAQ:TTOO) saw 0.48 million shares changing hands at last check today with its beta currently measuring 0.38. Company’s recent per share price level of $0.33 trading at -$0.03 or -8.76% at last check today assigns it a market valuation of $9.22M. That most recent trading price of TTOO’s stock is at a discount of -2006.06% from its 52-week high price of $6.95 and is indicating a premium of 6.06% from its 52-week low price of $0.31. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.94 million shares which gives us an average trading volume of 908.35K if we extend that period to 3-months.
T2 Biosystems Inc (NASDAQ:TTOO) trade information
Upright in the red during last session for losing -8.76%, in the last five days TTOO remained trading in the red while hitting it’s week-highest on Tuesday, 01/07/25 when the stock touched $0.33 price level, adding 23.26% to its value on the day. T2 Biosystems Inc’s shares saw a change of -21.77% in year-to-date performance and have moved -17.86% in past 5-day. T2 Biosystems Inc (NASDAQ:TTOO) showed a performance of -36.82% in past 30-days. Number of shares sold short was 0.83 million shares which calculate 1.26 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 5 to the stock, which implies a rise of 93.4% to its recent value today. Analysts have been projecting 5 as a low price target for the stock while placing it at a high target of 5. It follows that stock’s current price would drop -1415.15% in reaching the projected high whereas dropping to the targeted low would mean a loss of -1415.15% for stock’s current value.
T2 Biosystems Inc (NASDAQ:TTOO)’s Major holders
Insiders are in possession of 10.17% of company’s total shares while institution are holding 73.51 percent of that, with stock having share float percentage of 81.83%. Investors also watch the number of corporate investors in a company very closely, which is 73.51% institutions for T2 Biosystems Inc that are currently holding shares of the company.
On the other hand, Vanguard Extended Market Index Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024, the former fund manager was holding 229.85 shares of worth $74769.0 or 1.09% of the total outstanding shares. The later fund manager was in possession of 154.81 shares on Sep 30, 2024, making its stake of worth around $50360.0 in the company or a holder of 0.74% of company’s stock.
